These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 32800728)

  • 1. Re: Lisa Moris, Marcus G. Cumberbatch, Thomas Van den Broeck, et al. Benefits and Risks of Primary Treatments for High-risk Localized and Locally Advanced Prostate Cancer: An International Multidisciplinary Systematic Review. Eur Urol 2020;77:614-27.
    Montorsi F; Salonia A; Briganti A
    Eur Urol; 2020 Nov; 78(5):e192. PubMed ID: 32800728
    [No Abstract]   [Full Text] [Related]  

  • 2. Re: Lisa Moris, Marcus G. Cumberbatch, Thomas Van den Broeck, et al. Benefits and Risks of Primary Treatments for High-risk Localized and Locally Advanced Prostate Cancer: An International Multidisciplinary Systematic Review. Eur Urol 2020;77:614-27.
    Gregucci F; Carbonara R; Fiorentino A
    Eur Urol; 2020 Sep; 78(3):e114-e115. PubMed ID: 32534911
    [No Abstract]   [Full Text] [Related]  

  • 3. Re: Lisa Moris, Marcus G. Cumberbatch, Thomas Van den Broeck, et al. Benefits and Risks of Primary Treatments for High-risk Localized and Locally Advanced Prostate Cancer: An International Multidisciplinary Systematic Review. Eur Urol 2020;77:614-27.
    Funada S; Yoshioka T; Luo Y
    Eur Urol; 2020 Sep; 78(3):e118-e119. PubMed ID: 32682614
    [No Abstract]   [Full Text] [Related]  

  • 4. Reply to Fabiana Gregucci, Roberta Carbonara, and Alba Fiorentino's Letter to the Editor re: Lisa Moris, Marcus G. Cumberbatch, Thomas Van den Broeck, et al. Benefits and Risks of Primary Treatments for High-risk Localized and Locally Advanced Prostate Cancer: An International Multidisciplinary Systematic Review. Eur Urol 2020;77:614-27.
    Moris L; Mottet N; Wiegel T
    Eur Urol; 2020 Sep; 78(3):e116-e117. PubMed ID: 32536484
    [No Abstract]   [Full Text] [Related]  

  • 5. Reply to Satoshi Funada, Takashi Yoshioka, and Yan Luo's Letter to the Editor re: Lisa Moris, Marcus G. Cumberbatch, Thomas Van den Broeck, et al. Benefits and Risks of Primary Treatments for High-risk Localized and Locally Advanced Prostate Cancer: An International Multidisciplinary Systematic Review. Eur Urol 2020;77:614-27.
    Moris L; Van den Broeck T; Wiegel T;
    Eur Urol; 2020 Sep; 78(3):e120-e121. PubMed ID: 32684306
    [No Abstract]   [Full Text] [Related]  

  • 6. Reply to Francesco Montorsi, Andrea Salonia, and Alberto Briganti's Letter to the Editor re: Lisa Moris, Marcus G. Cumberbatch, Thomas Van den Broeck, et al. Benefits and Risks of Primary Treatments for High-risk Localized and Locally Advanced Prostate Cancer: An International Multidisciplinary Systematic Review. Eur Urol 2020;77:614-27.
    Moris L; Mottet N; Wiegel T;
    Eur Urol; 2020 Nov; 78(5):e193-e194. PubMed ID: 32838999
    [No Abstract]   [Full Text] [Related]  

  • 7. Re: Thomas Van den Broeck, Roderick C.N. van den Bergh, Nicolas Arfi, et al. Prognostic Value of Biochemical Recurrence Following Treatment with Curative Intent for Prostate Cancer: A Systematic Review. Eur Urol 2019;75:967-87.
    Zhou X; Han X
    Eur Urol; 2019 Jul; 76(1):e15. PubMed ID: 30948226
    [No Abstract]   [Full Text] [Related]  

  • 8. Reply to Xueliang Zhou and Xinwei Han's Letter to the Editor re: Thomas Van den Broeck, Roderick C.N. van den Bergh, Nicolas Arfi, et al. Prognostic Value of Biochemical Recurrence Following Treatment with Curative Intent for Prostate Cancer: A Systematic Review. Eur Urol 2019;75:967-87.
    Van den Broeck T; Mottet N; Lam T
    Eur Urol; 2019 Jul; 76(1):e16. PubMed ID: 30967298
    [No Abstract]   [Full Text] [Related]  

  • 9. Re: Nicola Fossati, Peter-Paul M. Willemse, Thomas Van den Broeck, et al. The Benefits and Harms of Different Extents of Lymph Node Dissection During Radical Prostatectomy for Prostate Cancer: A Systematic Review. Eur Urol 2017;72:84-109: Lymphadenectomy and Radical Prostatectomy: Science or Pseudoscience?
    Clarke NW
    Eur Urol; 2018 Mar; 73(3):e75-e76. PubMed ID: 28579297
    [No Abstract]   [Full Text] [Related]  

  • 10. Re: Maria Chiara Sighinolfi, Bernardo Rocco's Words of Wisdom re: EAU Guidelines: Prostate Cancer 2019. Mottet N, van den Bergh RCN, Briers E, et al. https://uroweb.org/guideline/prostate-Cancer/. Eur Urol 2019;76:871.
    Cimadamore A; Scarpelli M; Cheng L; Lopez-Beltran A; Galosi AB; Montorsi F; Montironi R
    Eur Urol; 2020 May; 77(5):e122-e127. PubMed ID: 32089357
    [No Abstract]   [Full Text] [Related]  

  • 11. Re: Henk G. van der Poel, Roderick C.N. van den Bergh, Erik Briers, et al. Focal Therapy in Primary Localised Prostate Cancer: The European Association of Urology Position in 2018. Eur Urol 2018;74:84-91.
    Valerio M; Emberton M; Ahmed HU
    Eur Urol; 2019 Feb; 75(2):e21-e22. PubMed ID: 30224194
    [No Abstract]   [Full Text] [Related]  

  • 12. Re: Philip Cornford, Roderick C.N. van den Bergh, Erik Briers, et al. EAU-ESTRO-ESUR-SIOG Guidelines on Prostate Cancer. Part II-2020 Update: Treatment of Relapsing and Metastatic Prostate Cancer. Eur Urol 2021;79:263-82.
    von Eyben FE
    Eur Urol; 2021 Jun; 79(6):e176. PubMed ID: 33712301
    [No Abstract]   [Full Text] [Related]  

  • 13. Reply to Alessia Cimadamore, Marina Scarpelli, Liang Cheng, et al's Letter to the Editor, re: Maria Chiara Sighinolfi, Bernardo Rocco's Words of Wisdom re: EAU Guidelines: Prostate Cancer 2019. Mottet N, van den Bergh RCN, Briers E, et al. https://uroweb.org/guideline/prostate-Cancer/. Eur Urol 2019, 76:871.
    Sighinolfi MC; Rocco B
    Eur Urol; 2020 May; 77(5):e128-e129. PubMed ID: 32067794
    [No Abstract]   [Full Text] [Related]  

  • 14. Re: Yaw A. Nyame, Matthew R. Cooperberg, Marcus G. Cumberbatch, et al. Deconstructing, Addressing, and Eliminating Racial and Ethnic Inequities in Prostate Cancer Care. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2022.03.007.
    Wei Y; Ye D; Zhu Y
    Eur Urol; 2022 Aug; 82(2):e51. PubMed ID: 35599186
    [No Abstract]   [Full Text] [Related]  

  • 15. Re: Katharina Beyer, Lisa Moris, Michael Lardas, et al. Updating and Integrating Core Outcome Sets for Localised, Locally Advanced, Metastatic, and Nonmetastatic Castration-resistant Prostate Cancer: An Update from the PIONEER Consortium. Eur Urol 2022;81:503-14.
    Lei R; Li Y; Chen Y
    Eur Urol; 2022 Sep; 82(3):e67. PubMed ID: 35644770
    [No Abstract]   [Full Text] [Related]  

  • 16. Re: Yaw A. Nyame, Matthew R. Cooperberg, Marcus G. Cumberbatch, et al. Deconstructing, Addressing, and Eliminating Racial and Ethnic Inequities in Prostate Cancer Care. Eur Urol 2022;82:341-51.
    Sirufo MM; Ginaldi L; De Martinis M
    Eur Urol; 2023 Apr; 83(4):e102. PubMed ID: 36670032
    [No Abstract]   [Full Text] [Related]  

  • 17. Re: Nicolas Mottet, Roderick C.N. van den Bergh, Erik Briers, et al. EAU-EANM-ESTRO-ESUR-SIOG Guidelines on Prostate Cancer-2020 Update. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent. Eur Urol 2021;79:243-62: Comorbidity Measurement in Patients with Prostate Cancer.
    Froehner M; Koch R; Graefen M
    Eur Urol; 2021 May; 79(5):e138. PubMed ID: 33612374
    [No Abstract]   [Full Text] [Related]  

  • 18. Reply to Thomas Van den Broeck, R. Jeffrey Karnes, and Steven Joniau's Letter to the Editor re: Amar U. Kishan, Talha Shaikh, Pin-Chieh Wang, et al. Clinical Outcomes for Patients with Gleason Score 9-10 Prostate Adenocarcinoma Treated With Radiotherapy or Radical Prostatectomy: A Multi-institutional Comparative Analysis. Eur Urol 2017;71:766-73.
    Kishan AU; Steinberg ML; Kupelian PA; King CR
    Eur Urol; 2017 Nov; 72(5):e123-e124. PubMed ID: 28111115
    [No Abstract]   [Full Text] [Related]  

  • 19. Reply from Authors re: Roderick C.N. van den Bergh, Declan G. Murphy, Henk G. van der Poel. Expectant Management for Prostate Cancer: Lessons from the Past, Challenges for the Future. Eur Urol 2016;70:767-8.
    Godtman RA; Stranne J; Hugosson J
    Eur Urol; 2016 Nov; 70(5):769-770. PubMed ID: 27210462
    [No Abstract]   [Full Text] [Related]  

  • 20. Re: Steven Joniau, Laura Van den Bergh, Evelyne Lerut, et al. Mapping of pelvic lymph node metastases in prostate cancer. Eur Urol 2013;63:450-8.
    Kim KH; Rha KH
    Eur Urol; 2013 Sep; 64(3):e55-6. PubMed ID: 23746720
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.